STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about AUBN
Insiders, 180 days
+$38.4K net bought
5 buyers
Auburn National Bancorporation insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AUBURN NATIONAL BANCORPORATION, INC insiders bought a net $38.4K of stock across 241 Form 4 purchases and sales, with 5 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AUBN planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · David A. Hedges
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$489.6K
$488.9K
$315.6K
+36%
n/a
2024
$393.2K
$393.2K
$282.3K
+13%
n/a
2023
$341.2K
$341.2K
$271.1K
-3%
n/a
2022
$519.8K
$519.8K
$290.7K
-26%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
5 insiders reported buying shares.
The record shows a net $38.4K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$618.0K
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AUBN
FY Dec 2025
$619.0K
FY Dec 2024
$614.0K
FY Dec 2023
$603.0K
FY Dec 2022
$598.0K
FY Dec 2021
$566.0K
Jun 2026
$153.0K
Mar 2026
$153.0K
Dec 2025
$158.0K
Sep 2025
$154.0K
Jun 2025
$152.0K
Mar 2025
$155.0K
Dec 2024
$151.0K
Sep 2024
$154.0K
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2018-09-30 (94 months older than the period end); equity 2026-06-30
Debt to equity AUBN
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.00x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+9.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AUBN
FY Dec 2025
+8.5%
FY Dec 2024
+8.3%
FY Dec 2023
+1.9%
FY Dec 2022
+12.0%
FY Dec 2021
+7.6%
Jun 2026
+9.3%
Mar 2026
+9.0%
Dec 2025
+8.5%
Sep 2025
+8.2%
Jun 2025
+8.3%
Mar 2025
+8.3%
Dec 2024
+8.3%
Sep 2024
+1.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AUBN
FY Dec 2025
+0.7%
FY Dec 2024
+0.7%
FY Dec 2023
+0.1%
FY Dec 2022
+1.0%
FY Dec 2021
+0.8%
Jun 2026
+0.8%
Mar 2026
+0.8%
Dec 2025
+0.7%
Sep 2025
+0.7%
Jun 2025
+0.6%
Mar 2025
+0.7%
Dec 2024
+0.7%
Sep 2024
+0.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.60x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing AUBN
FY Dec 2025
12.96x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
11.22x
Mar 2026
10.52x
Dec 2025
12.96x
Sep 2025
13.87x
Jun 2025
13.09x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.40x
P/E over trailing EPS growth of 26%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing AUBN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.43x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AUBN ranks highest on financial health (99th percentile) and insider conviction (84th), and lowest on growth (25th), among Banks peers.
Profitability
33
Inputs
Return on equity+9.3% · 39 pct, sector of 327
Return on assets+0.8% · 26 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 229
Cash flow to debtno debt to cover
Growth
25
Inputs
Revenue growth, YoY+0.8% · 25 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
84
Inputs
Net Form 4 buying (codes P and S), 180d$38K · 78 pct, sector of 273
Insider buyers, 180d5 · 91 pct, sector of 273
Risk and compliance
43
Inputs
Short interest, % of float+0.3% · 82 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+55.2% · 5 pct, sector of 127
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AUBN filings, in plain words
Are Auburn National Bancorporation insiders buying or selling AUBN?
In the 180 days to 2026-10-28, Auburn National Bancorporation insiders were net buyers, a net $38.4K across purchases and sales reported on Form 4, by 5 buyers.
Read the full summary
In the 180 days to 2026-10-28, Auburn National Bancorporation insiders were net buyers of AUBN, a net $38.4K across purchases and sales reported on Form 4 by 5 buyers. 4 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.